Hepatic insulin resistance manifests predominantly as increased gluconeogenesis and fasting hyperglycemia, primarily associated with the dysregulation of forkhead box protein O1 (FoxO1) transcription factor [1,11]. The gene discussed is FOXO1; the disease is Hyperglycemia.